Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (315)	7/1/1998 12:09:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 4474

Steve: I'd say that the technology can put Novartis/GTI/SyStemix and several other outfits out of business. Yes, the agreement will be interesting (Novartis?). However, the magnitude will be determined by the breadth of protection that is being written into CIPs. ARIA is going to need the best regulatory group in the business. Also, they need to develop animal models, relating to "tox", with foresight. Then they need to drive those models home with relentless and exacting science. I hope that they are talking to BTRN, looking for the "reaching" applications of the technology (manipulation of mixed bone marrow chimeras). Rick